- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2023
-
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
(2023)
In Cell Stem Cell
30(10).
p.1299-1314
- Contribution to journal › Article
-
Athymic Nude Rat Brain Atlas
(2023)
- Book/Report › Book
-
Restorative cell and gene therapies for Parkinson's disease
(2023)
In Handbook of Clinical Neurology
193.
p.211-226
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2022
-
A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System
(2022)
In Journal of Parkinson's Disease
12(8).
p.2307-2320
- Contribution to journal › Scientific review
- 2021
-
In vivo conversion of dopamine neurons in mouse models of Parkinson's disease - a future approach for regenerative therapy?
(2021)
In Current Opinion in Genetics & Development
70.
p.76-82
- Contribution to journal › Scientific review
-
Stem Derived Dopamine Neurons : Will They Replace DBS as the Leading Neurosurgical Treatment for Parkinson's Disease?
(2021)
In Journal of Parkinson's Disease
11(3).
p.909-917
- Contribution to journal › Article
-
GDNF Therapy : Can We Make It Work?
(2021)
In Journal of Parkinson's Disease
11(3).
p.1019-1022
- Contribution to journal › Article
-
Repairing the Parkinson Brain
(2021)
In Journal of Parkinson's Disease
11(s2).
p.123-125
- Contribution to journal › Debate/Note/Editorial
-
Grafts Derived from an α-Synuclein Triplication Patient Mediate Functional Recovery but Develop Disease-Associated Pathology in the 6-OHDA Model of Parkinson's Disease
(2021)
In Journal of Parkinson's Disease
11(2).
p.515-528
- Contribution to journal › Article
-
Dopamine Cell Therapy : From Cell Replacement to Circuitry Repair
(2021)
In Journal of Parkinson's Disease
11(s2).
p.159-165
- Contribution to journal › Scientific review